Eton Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	86.93	79.95	39.01	31.64	21.25	21.83
Revenue Growth	79.89%	104.94%	23.29%	48.90%	-2.66%	55879.49%
Cost of Revenue	39.32	37.21	15.6	10.58	6.93	2.83
Gross Profit	47.61	42.74	23.41	21.06	14.32	19.01
Selling, General & Admin	37.1	35.82	22.75	18.93	18.58	14.27
Research & Development	8.48	7.77	3.26	3.32	4	6.24
Total Operating Expenses	45.57	43.58	26.01	22.25	22.58	20.5
Operating Income	2.04	-0.84	-2.6	-1.19	-8.26	-1.5
Total Non-Operating Income (Expense)	-3.53	-3.71	-1.21	0.5	-0.76	-0.46
Pretax Income	-1.49	-4.56	-3.81	-0.69	-9.02	-1.96
Provision for Income Taxes	-0.01	0.04	0.02	0.25	-	-
Net Income	-1.48	-4.6	-3.82	-0.94	-9.02	-1.96
Net Income to Common	-1.48	-4.6	-3.82	-0.94	-9.02	-1.96
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	27	27	26	26	25	25
Shares Outstanding (Diluted)	29	27	26	26	25	25
Shares Change	10.66%	3.91%	0.97%	1.99%	-0.24%	19.98%
EPS (Basic)	-0.05	-0.17	-0.15	-0.04	-0.36	-0.08
EPS (Diluted)	-0.07	-0.17	-0.15	-0.04	-0.36	-0.08
EPS Growth	-	-	-	-	-	-
Free Cash Flow	15.84	10.19	0.94	6.82	4.78	-4.73
Free Cash Flow Growth	186.94%	980.70%	-86.16%	42.48%	-	-
Free Cash Flow Per Share	0.54	0.38	0.04	0.27	0.19	-0.19
Gross Margin	54.77%	53.46%	60.01%	66.56%	67.38%	87.05%
Operating Margin	2.35%	-1.06%	-6.66%	-3.77%	-38.87%	-6.85%
Profit Margin	-1.70%	-5.75%	-9.80%	-2.96%	-42.45%	-8.95%
FCF Margin	18.22%	12.75%	2.42%	21.54%	22.51%	-21.67%
EBITDA	6.2	3.2	-1.45	-0.29	-6.49	-1.03
EBITDA Margin	7.13%	4.00%	-3.72%	-0.92%	-30.52%	-4.73%
EBIT	2.04	-0.84	-2.6	-1.19	-8.26	-1.5
EBIT Margin	2.35%	-1.06%	-6.66%	-3.77%	-38.87%	-6.85%
Effective Tax Rate	0.74%	-0.94%	-0.39%	-35.85%	0.00%	0.00%

SEC Filings: 10-K · 10-Q